X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMAR REMEDIES Share Price   (AMAD)

Here is the latest stock price and chart of AMAR REMEDIES. For more details, see the AMAR REMEDIES company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.

REFRESH
Live BSE Quotes Dec 11, 2013 (Close)
Price (Rs)6.07 Open (Rs) 6.04 High (Rs) 6.34 Low (Rs) 5.74
% Change0.50 Volume 139,679 Value (Rs) 854,123 52-Week H/L 48.00 / 5.48
Live NSE Quotes Dec 10, 2013 03:25:00 PM
Price (Rs)- Open (Rs) 5.90 High (Rs) 6.10 Low (Rs) 5.80
% Change-4.92 Volume 60,361 Value (Rs) 352,945 52-Week H/L 48.20 / 5.80
Valuation
EPS (Rs)* -12.04 P/E Ratio (x) NM Market Cap (Rs m) 158.79 P/BV (x) 0.06
  *Trailing 12 months earnings, excluding extraordinary / exceptional items. BSE Sensex | CNX Nifty

Charts
AMAR REMEDIES Share Price Chart (Rs) - 1 Year
Loading...
 
     
 S&P BSE SENSEX 
PERIOD
Advanced Charts new


Today's Market

Monetary Policy; Q1 Earnings & Top Cues in Action Today(Pre-Open)

Indian share markets finished marginally lower on Thursday as IT stocks, metal stocks, and automobile stocks witnessed selling pressure. The top movers were Axis Bank, ONGC and Kotak Bank.

Related Views On News

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

Lupin: Decline in US Business Impacts Overall Growth (Quarterly Results Update - Detailed)

May 29, 2017

Currency fluctuation and one time provision impacts operating margins.

Glenmark Pharma: Lower Zetia Sales leads to Subdued Growth (Quarterly Results Update - Detailed)

May 18, 2017

Base price erosion in the US and lower Zetia sales impacts profits.

Sun Pharma: Slow Growth Across Major Markets (Quarterly Results Update - Detailed)

Mar 11, 2017

Sun Pharma has announced its December quarter (3QFY17) results. The company has reported 8% YoY growth in sales and a decline of 4.7% YoY in the net profits.

More Views on News

Most Popular

Post Demonetisation Real Estate Sales Have Collapsed, But Prices Haven't(Vivek Kaul's Diary)

Jul 11, 2017

While sales have fallen dramatically, net net home prices continue to hold on.

Ride the Bull Wave with These Perfect Proxies to India's Growth Story(The 5 Minute Wrapup)

Jul 15, 2017

The secret of spotting multibaggers before they become a hit.

The New Pharma Rally Starts NOW(Daily Profit Hunter)

Jul 12, 2017

The most hated sector is offering the best trading opportunity. Are you ready?

All You Need To Know To e-File Your Income Tax Returns(Outside View)

Jul 12, 2017

The Income Tax return filing deadline is drawing near; if you have not already filed your taxes, here's how to do it.

Warren Buffett's Long Term Returns Immune to Volatility(Chart Of The Day)

Jul 8, 2017

Buffett's periodic underperformance to index fund.

More

TRACK AMAR REMEDIES

  • Track your investment in AMAR REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AMAR REMEDIES 5-YR ANALYSIS

COMPARE AMAR REMEDIES WITH

MARKET STATS